CPRX: カタリスト・ファーマシューティカルズ

CPRX News

• 15:40 CPRX or UTHR: Which Is the Better Value Stock Right Now?
• 14:22 KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data
• 14:28 NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program
• 13:00 The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
• 17:13 Theravance Stock Declines Around 17% in Three Months: Here's Why
• 15:26 SMMT Stock Up 24% in Three Months: Here's What You Need to Know
• 13:40 TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi
• 13:35 NTLA Stock Rises 20% in 3 Months: Here's What You Should Know
• 14:37 TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication
• 14:17 NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up
• 14:09 CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
• 13:55 Does Catalyst (CPRX) Have the Potential to Rally 28.87% as Wall Street Analysts Expect?
• 16:37 KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
• 16:31 RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
• 16:14 ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study
• 15:31 Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
• 13:44 SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria
• 18:54 IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
• 16:04 KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
• 12:30 If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now
• 14:29 ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know
• 12:55 Recent Price Trend in Catalyst (CPRX) is Your Friend, Here's Why
• 15:23 Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why
• 12:36 Insmed Ends Brinsupri Development in Skin Disease Post Study Failure